全文获取类型
收费全文 | 4550篇 |
免费 | 140篇 |
国内免费 | 303篇 |
出版年
2024年 | 4篇 |
2023年 | 43篇 |
2022年 | 43篇 |
2021年 | 65篇 |
2020年 | 57篇 |
2019年 | 145篇 |
2018年 | 160篇 |
2017年 | 178篇 |
2016年 | 145篇 |
2015年 | 96篇 |
2014年 | 380篇 |
2013年 | 516篇 |
2012年 | 184篇 |
2011年 | 242篇 |
2010年 | 182篇 |
2009年 | 228篇 |
2008年 | 237篇 |
2007年 | 232篇 |
2006年 | 210篇 |
2005年 | 190篇 |
2004年 | 154篇 |
2003年 | 153篇 |
2002年 | 131篇 |
2001年 | 85篇 |
2000年 | 85篇 |
1999年 | 86篇 |
1998年 | 94篇 |
1997年 | 66篇 |
1996年 | 93篇 |
1995年 | 71篇 |
1994年 | 64篇 |
1993年 | 55篇 |
1992年 | 55篇 |
1991年 | 50篇 |
1990年 | 37篇 |
1989年 | 33篇 |
1988年 | 19篇 |
1987年 | 30篇 |
1986年 | 16篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有4993条查询结果,搜索用时 15 毫秒
161.
目的:通过有限元法,探讨高嵌体修复根管治疗后的下颌第一磨牙后,牙体预备形式对牙体组织受力的影响,为临床提供力学理论依据。方法:模拟右侧下颌第一磨牙的三维有限元模型,磨牙存在合面I类洞缺损,根管治疗后采用高嵌体修复,分别设计三种牙体预备形式,即覆盖全部牙尖、覆盖全部功能尖和覆盖部分功能尖的高嵌体修复,对模型进行加载,观察牙体组织的应力大小及分布。结果:覆盖全部牙尖高嵌体修复时牙釉质出现一个应力集中区,其他两种设计出现两个应力集中区。垂直载荷下,釉质的最大主应力在全部牙尖组分别低于其他两组92.29%和89.76%;舌颊向载荷下比其他两组分别降低80.91%和76.53%。三组牙本质的应力集中区趋于一致。垂直载荷下,牙本质的最大主应力在全部牙尖组分别高出其他两组12.92%和14.73%;舌颊向载荷下较其他两组高1.26%和5.08%。结论:从生物力学角度,覆盖全部牙尖的高嵌体更有利于牙体硬组织的受力,可以更好的对牙釉质起到保护作用。 相似文献
162.
163.
164.
Transposable elements are present in almost all genomes including that of humans. These mobile DNA sequences are capable of invading genomes and their impact on genome evolution is substantial as they contribute to the genetic diversity of organisms. The mobility of transposable elements can cause deleterious mutations, gene disruption and chromosome rearrangements that may lead to several pathologies including cancer. This mini-review aims to give a brief overview of the relationship that transposons and retrotransposons may have in the genetic cause of human cancer onset, or conversely creating protection against cancer. Finally, the cause of TE mobility may also be the cancer cell environment itself. 相似文献
165.
Bruno Ramos-Molina Ana LambertosAndrés J. López-Contreras Rafael Peñafiel 《Biochimica et Biophysica Acta (BBA)/General Subjects》2013
Background
Ornithine decarboxylase (ODC), the key enzyme in the polyamine biosynthetic pathway, is highly regulated by antizymes (AZs), small proteins that bind and inhibit ODC and increase its proteasomal degradation. Early studies delimited the putative AZ-binding element (AZBE) to the region 117-140 of ODC. The aim of the present work was to study the importance of certain residues of the region 110-142 that includes the AZBE region for the interaction between ODC and AZ1 and the ODC functionality.Methods
Computational analysis of the protein sequences of the extended AZBE site of ODC and ODC paralogues from different eukaryotes was used to search for conserved residues. The influence of these residues on ODC functionality was studied by site directed mutagenesis, followed by different biochemical techniques.Results
The results revealed that: a) there are five conserved residues in ODC and its paralogues: K115, A123, E138, L139 and K141; b) among these, L139 is the most critical one for the interaction with AZs, since its substitution decreases the affinity of the mutant protein towards AZs; c) all these conserved residues, with the exception of A123, are critical for ODC activity; d) substitutions of K115, E138 or L139 diminish the formation of ODC homodimers.Conclusions
These results reveal that four of the invariant residues of the AZBE region are strongly related to ODC functionality.General significance
This work helps to understand the interaction between ODC and AZ1, and describes various new residues involved in ODC activity, a key enzyme for cell growth and proliferation. 相似文献166.
Atanas G. Atanasov Jian N. Wang Shi P. Gu Jing Bu Matthias P. Kramer Lisa Baumgartner Nanang Fakhrudin Angela Ladurner Clemens Malainer Anna Vuorinen Stefan M. Noha Stefan Schwaiger Judith M. Rollinger Daniela Schuster Hermann Stuppner Verena M. Dirsch Elke H. Heiss 《Biochimica et Biophysica Acta (BBA)/General Subjects》2013
Background
Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are clinically used to counteract hyperglycemia. However, so far experienced unwanted side effects, such as weight gain, promote the search for new PPARγ activators.Methods
We used a combination of in silico, in vitro, cell-based and in vivo models to identify and validate natural products as promising leads for partial novel PPARγ agonists.Results
The natural product honokiol from the traditional Chinese herbal drug Magnolia bark was in silico predicted to bind into the PPARγ ligand binding pocket as dimer. Honokiol indeed directly bound to purified PPARγ ligand-binding domain (LBD) and acted as partial agonist in a PPARγ-mediated luciferase reporter assay. Honokiol was then directly compared to the clinically used full agonist pioglitazone with regard to stimulation of glucose uptake in adipocytes as well as adipogenic differentiation in 3T3-L1 pre-adipocytes and mouse embryonic fibroblasts. While honokiol stimulated basal glucose uptake to a similar extent as pioglitazone, it did not induce adipogenesis in contrast to pioglitazone. In diabetic KKAy mice oral application of honokiol prevented hyperglycemia and suppressed weight gain.Conclusion
We identified honokiol as a partial non-adipogenic PPARγ agonist in vitro which prevented hyperglycemia and weight gain in vivo.General significance
This observed activity profile suggests honokiol as promising new pharmaceutical lead or dietary supplement to combat metabolic disease, and provides a molecular explanation for the use of Magnolia in traditional medicine. 相似文献167.
Starting in 1991, the advance of Tyr-recombinases Flp and Cre enabled superior strategies for the predictable insertion of transgenes into compatible target sites of mammalian cells. Early approaches suffered from the reversibility of integration routes and the fact that co-introduction of prokaryotic vector parts triggered uncontrolled heterochromatization. Shortcomings of this kind were overcome when Flp-Recombinase Mediated Cassette Exchange entered the field in 1994. RMCE enables enhanced tag-and-exchange strategies by precisely replacing a genomic target cassette by a compatible donor construct. After “gene swapping” the donor cassette is safely locked in, but can nevertheless be re-mobilized in case other compatible donor cassettes are provided (“serial RMCE”). These features considerably expand the options for systematic, stepwise genome modifications. The first decade was dominated by the systematic generation of cell lines for biotechnological purposes. Based on the reproducible expression capacity of the resulting strains, a comprehensive toolbox emerged to serve a multitude of purposes, which constitute the first part of this review. The concept per se did not, however, provide access to high-producer strains able to outcompete industrial multiple-copy cell lines. This fact gave rise to systematic improvements, among these certain accumulative site-specific integration pathways. The exceptional value of RMCE emerged after its entry into the stem cell field, where it started to contribute to the generation of induced pluripotent stem (iPS-) cells and their subsequent differentiation yielding a variety of cell types for diagnostic and therapeutic purposes. This topic firmly relies on the strategies developed in the first decade and can be seen as the major ambition of the present article. In this context an unanticipated, potent property of serial Flp-RMCE setups concerns the potential to re-open loci that have served to establish the iPS status before the site underwent the obligatory silencing process. Other relevant options relate to the introduction of composite Flp-recognition target sites (“heterospecific FRT-doublets”), into the LTRs of lentiviral vectors. These “twin sites” enhance the safety of iPS re-programming and -differentiation as they enable the subsequent quantitative excision of a transgene, leaving behind a single “FRT-twin”. Such a strategy combines the established expression potential of the common retro- and lentiviral systems with options to terminate the process at will. The remaining genomic tag serves to identify and characterize the insertion site with the goal to identify genomic “safe harbors” (GOIs) for re-use. This is enabled by the capacity of “FRT-twins” to accommodate any incoming RMCE-donor cassette with a compatible design. 相似文献
168.
169.
170.